Rigenerand Srl

RR001, a cell-based gene therapy administered in combination with chemotherapy for the treatment of patients with locally advanced pancreatic cancer. Phase I /IIa clinical trial (open label and non-randomized) to test the effects (safety & efficacy) of increasing doses of RR001.